Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Generic drugmaker Hetero has received Drug Controller General of India approval to manufacture and sell its generic version of Gilead’s Ramdesivir for the treatment of COVID-19 patients. The generic version will be marked under the brand name ‘Covifor’ in India. Covifor will be available in 100-milligram vial ( injectable)  which has to be administrated intravenously in a hospital setting under the supervision of a health care practitioner. The product is being manufactured at its facility in Hyderabad. 

Banner Ad

DCGI has granted approval for the use of Remidviser in the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease. Covifor will be available in 100-milligram vial ( injectable)  which has to be administrated intravenously in a hospital setting under the supervision of a health care practitioner.   

https://youtu.be/Np5W8dqk1do

 Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

 

read more:

Glenmark launches COVID-19 drug after DCGI nod 
Glenmark launches COVID-19 drug after DCGI nod
First steel bridge in Hyderabad inaugurated
First steel bridge in Hyderabad inaugurated

No more lockdowns, only unlocking
No more lockdowns, only unlocking
Coronavirus cases in Telangana – 21-06-2020 – charan news
Coronavirus cases in Telangana – 21-06-2020 – charan news
Coronavirus treatment drug: Hetero launches drug for COVID-19 patients
Coronavirus treatment drug: Hetero launches drug for COVID-19 patients

Leave a Reply

Your email address will not be published. Required fields are marked *